# Bruker (Bruker Spatial Biology)

Source: https://onco.cc/companies/bruker/  
OnCo record `bruker` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Scientific-instrument group that acquired NanoString (GeoMx, CosMx) out of bankruptcy in 2024 to form Bruker Spatial Biology.

## Summary

Bruker, based in Billerica, Massachusetts, and listed as BRKR, is a scientific instrument group that acquired NanoString, maker of GeoMx and CosMx, out of bankruptcy in 2024 to form Bruker Spatial Biology. Its portfolio spans mass spectrometry including the timsTOF instruments for proteomics, NMR and spatial biology instruments, with CosMx providing single-cell spatial imaging. OnCo links it to spatial biology instruments, proteomics and phosphoproteomics, and proteomics instruments and affinity platforms. Whether a diversified instrument company can turn a rescued spatial biology business into a clinical tool rather than a research product is the open question. The spatial biology instruments page carries the wider field.

## Fields

- Kind: Company
- Last checked: 2026-09-08
- Tags: supporting
- HQ: Billerica, MA
- Type: diagnostics
- Website: https://www.bruker.com
- Ticker: BRKR

## Sources

- Official website: https://www.bruker.com

## Connected records

- fronts: [Diagnostics & Biomarkers](https://onco.cc/fronts/diagnostics/), [Drug Discovery Platforms](https://onco.cc/fronts/drug-discovery/)
- technologies: [CT, MRI and PET scanner manufacturing](https://onco.cc/technologies/medical-imaging-scanner-manufacturing/), [MRI field strengths: 1.5 T, 3 T and 7 T](https://onco.cc/technologies/mri-field-strengths/), [Proteomics & phosphoproteomics](https://onco.cc/technologies/proteomics/), [Proteomics instruments and affinity platforms](https://onco.cc/technologies/proteomics-platforms/), [Spatial biology instruments](https://onco.cc/technologies/spatial-biology-instruments/)

---
JSON: https://onco.cc/api/v1/entities/bruker.json